Literature DB >> 32420090

Iliofemoral lysis for DVT remains ATTRACTive.

Catherine Go1, Efthymios D Avgerinos1.   

Abstract

Year:  2020        PMID： 32420090      PMCID： PMC7225440          DOI： 10.21037/cdt.2019.08.08

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  8 in total

Review 1.  Just How Attractive is the ATTRACT Trial?

Authors:  Gerard J O'Sullivan; Rick de Graaf; Steven A Black
Journal:  Cardiovasc Intervent Radiol       Date:  2018-06-26       Impact factor: 2.740

2.  Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis.

Authors:  Anthony J Comerota; Clive Kearon; Chu-Shu Gu; Jim A Julian; Samuel Z Goldhaber; Susan R Kahn; Michael R Jaff; Mahmood K Razavi; Andrei L Kindzelski; Riyaz Bashir; Parag Patel; Mel Sharafuddin; Michael J Sichlau; Wael E Saad; Zakaria Assi; Lawrence V Hofmann; Margaret Kennedy; Suresh Vedantham
Journal:  Circulation       Date:  2019-02-26       Impact factor: 29.690

3.  The ATTRACTiveness of catheter-directed thrombolysis.

Authors:  Efthymios D Avgerinos; Rabih A Chaer
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2018-05

4.  Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry.

Authors:  M W Mewissen; G R Seabrook; M H Meissner; J Cynamon; N Labropoulos; S H Haughton
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

5.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Authors:  Tone Enden; Ylva Haig; Nils-Einar Kløw; Carl-Erik Slagsvold; Leiv Sandvik; Waleed Ghanima; Geir Hafsahl; Pål Andre Holme; Lars Olaf Holmen; Anne Mette Njaastad; Gunnar Sandbæk; Per Morten Sandset
Journal:  Lancet       Date:  2011-12-13       Impact factor: 79.321

6.  Single- versus multiple-stage catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis does not have an impact on iliac vein stent length or patency rates.

Authors:  Catherine Go; Zein Saadeddin; Yash Pandya; Rabih A Chaer; Mohammad H Eslami; Eric S Hager; Michael J Singh; Efthymios D Avgerinos
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2019-09-05

7.  Outcomes and predictors of failure of iliac vein stenting after catheter-directed thrombolysis for acute iliofemoral thrombosis.

Authors:  Efthymios D Avgerinos; Zein Saadeddin; Adham N Abou Ali; Yash Pandya; Eric Hager; Michael Singh; George Al-Khoury; Michel S Makaroun; Rabih A Chaer
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2019-01-16

8.  Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Jim A Julian; Susan R Kahn; Michael R Jaff; David J Cohen; Elizabeth Magnuson; Mahmood K Razavi; Anthony J Comerota; Heather L Gornik; Timothy P Murphy; Lawrence Lewis; James R Duncan; Patricia Nieters; Mary C Derfler; Marc Filion; Chu-Shu Gu; Stephen Kee; Joseph Schneider; Nael Saad; Morey Blinder; Stephan Moll; David Sacks; Judith Lin; John Rundback; Mark Garcia; Rahul Razdan; Eric VanderWoude; Vasco Marques; Clive Kearon
Journal:  N Engl J Med       Date:  2017-12-07       Impact factor: 176.079
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.